ERBB2 and cancer: We therefore further hypothesize that TD HER2 trogocytosis, which results in reduced target cancer cell HER2 expression, could induce target cancer cell death by pro-apoptotic proteins, such as granzymes and TNF-alpha, in addition to inducing trastuzumab-mediated ADCC.